Hunan Hansen Pharmaceutical Co Ltd
002412
Company Profile
Business description
Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.
Contact
Silver City Road
Long Ridge Industrial Park
Heshan District
Yiyang City413000
CHNT: +86 7376351079
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,536
Stocks News & Analysis
stocks
Better times ahead for these cheap ASX shares?
Our analysts think the outlook looks fairly good for these two undervalued and unloved ASX dividend payers.
video
ASX dividend stocks for 2025
With dividend yields at 25-year lows, it's time to rethink ASX stocks for income according to James Gruber.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,699.10 | 57.60 | -0.66% |
| CAC 40 | 8,147.05 | 59.51 | -0.73% |
| DAX 40 | 22,652.29 | 192.21 | -0.84% |
| Dow JONES (US) | 44,556.34 | 10.26 | 0.02% |
| FTSE 100 | 8,724.48 | 42.25 | -0.48% |
| HKSE | 22,944.24 | 32.57 | -0.14% |
| NASDAQ | 20,041.26 | 14.49 | 0.07% |
| Nikkei 225 | 39,164.61 | 105.79 | -0.27% |
| NZX 50 Index | 13,033.36 | 17.76 | -0.14% |
| S&P 500 | 6,129.58 | 14.95 | 0.24% |
| S&P/ASX 200 | 8,419.20 | 61.80 | -0.73% |
| SSE Composite Index | 3,351.54 | 27.05 | 0.81% |